SCHEMBL17827438

SCHEMBL17827438

c1ccc(-c2ccc(N(c3ccc(-c4cccc(-c5ccc(C6(c7ccccc7)c7ccccc7-c7ccccc76)cc5)c4)cc3)c3ccc4c(c3)oc3ccccc34)cc2)cc1

nearest known ligand 0.35

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 3/20 0.35
PLA2G4A P47712 3/20 0.35
KDM4E B2RXH2 2/20 0.33
MEN1 O00255 2/20 0.33
MAPT P10636 2/20 0.33
KMT2A Q03164 2/20 0.33
MMP12 P39900 1/20 0.33
MMP13 P45452 1/20 0.33
PLA2G10 O15496 1/20 0.33
LMNA P02545 1/20 0.33
OPRK1 P41145 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
AHR P35869 2/20 0.33
ALOX5 P09917 1/20 0.32
ALDH1A1 P00352 1/20 0.32
HPGD P15428 1/20 0.32
PDK2 Q15119 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18326179 0.97 MMP12 (0.36) PLA2G2APLA2G4AKDM4EMEN1MAPT
SCHEMBL17827434 0.96 KDM4E (0.33) PLA2G2APLA2G4AKDM4EMEN1MAPT
SCHEMBL17827454 0.96 MMP12 (0.33) PLA2G2APLA2G4AKDM4EMEN1MAPT
SCHEMBL17827475 0.96 MMP12 (0.33) PLA2G2APLA2G4AKDM4EMEN1MAPT
SCHEMBL17827459 0.96 MMP12 (0.33) PLA2G2APLA2G4AKDM4EMEN1MAPT
SCHEMBL17827464 0.96 MMP12 (0.33) PLA2G2APLA2G4AKDM4EMEN1MAPT
SCHEMBL21239192 0.96 KDM4E (0.33) PLA2G2APLA2G4AKDM4EMEN1MAPT
SCHEMBL17827430 0.96 MEN1 (0.36) PLA2G2APLA2G4AKDM4EMEN1MAPT
SCHEMBL18326161 0.94 MMP12 (0.37) PLA2G2APLA2G4AKDM4EMEN1MAPT
SCHEMBL18326168 0.94 MMP12 (0.37) PLA2G2APLA2G4AKDM4EMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9929355-B2 Amine compound and organic electroluminescent device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2018-03-27 US disclosed
US-9929355-B2 Amine compound and organic electroluminescent device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2018-03-27 US disclosed
US-20160172593-A1 AMINE COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2016-06-16 US disclosed
US-20160172593-A1 AMINE COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2016-06-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160172593-A1 AMINE COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME AOC2, SAT1, ODC1 PLA2G2A 3891/4885PLA2G4A 4413/4885KDM4E 595/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.